Very happy with my situation. K.G.G., Facebook Anxiety and Depression Worsened With GLP-1s My anxiety has worsened quite a bit since starting Ozempic
However, individual results vary significantly, and semaglutide has stronger cardiovascular outcomes data
Molecular Identity Developer Eli Lilly Mechanism Triple GLP-1, GIP, and glucagon receptor agonist FDA Status Under regulatory review (Phase 3 complete) Administration Weekly subcutaneous Triple-Agonist Mechanism Retatrutide combines all pathways: GLP-1: Core incretin signaling (shared with both Mazdutide and Tirzepatide) GIP: Second incretin pathway (shared with Tirzepatide, absent in Mazdutide) Glucagon: Hepatic energy expenditure (shared with Mazdutide, absent in Tirzepatide) For research examining the contributions of all three pathways, Retatrutide provides comprehensive coverage
This does not always mean something is wrong
These statements are based on managements current expectations, but actual results may differ materially due to various factors
Effects of Incretin Therapy on Skeletal Health in Type 2 DiabetesA Systematic Review. JBMR Plus , vol
